| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CORT | Common Stock | Tax liability | -$9.52K | -165 | -1.94% | $57.68 | 8.33K | Dec 2, 2024 | Direct | F1, F2, F3 |
| transaction | CORT | Common Stock | Award | $12.7K | +215 | +2.58% | $59.21 | 8.54K | Dec 2, 2024 | Direct | F3, F4, F5 |
| transaction | CORT | Common Stock | Award | $0 | +215 | +2.52% | $0.00 | 8.76K | Dec 2, 2024 | Direct | F3, F6 |
| Id | Content |
|---|---|
| F1 | These shares were withheld by the Issuer in order to satisfy certain withholding obligations in connection with the issuance of share upon the vesting of restricted stock units. |
| F2 | The closing price on November 29, 2024 was used to calculate the withholding obligation. |
| F3 | Includes 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 372 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| F4 | The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 2, 2024. |
| F5 | In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase. |
| F6 | Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary. |
Chief Accounting & Technology Officer